Literature DB >> 23165172

Comparative assessment of therapeutic response to physiotherapy with or without botulinum toxin injection using diffusion tensor tractography and clinical scores in term diplegic cerebral palsy children.

Saurabh K Chaturvedi1, Yogita Rai, Ankita Chourasia, Puneet Goel, Vimal K Paliwal, Ravindra K Garg, Ram Kishore S Rathore, Chandra M Pandey, Rakesh K Gupta.   

Abstract

The present study was to compare the effects of combined therapy [botulinum (BTX) plus physiotherapy] with physiotherapy alone using diffusion tensor imaging (DTI) derived fractional anisotropy (FA) values of motor and sensory fiber bundles and clinical grade of the disability to see the value of BTX in term children with spastic diplegic cerebral palsy (CP). Clinically diagnosed 36 children participated in the study. All these children were born at term, and had no history of seizures. The study was randomly categorized into two groups: group I (n=18) - physiotherapy alone and group II (n=18) - physiotherapy plus BTX injection. Quantitative diffusion tensor tractography on all these children was performed on motor and sensory fiber bundles on baseline as well as after 6months of therapy. Motor function and clinical grades were also measured by gross motor function measures (GMFM) scale on both occasions. We observed significant change in FA value in motor and sensory fiber bundle as well as in GMFM scores at 6months compared to baseline study in both the groups. However, delta change and relative delta change in FA values of sensory and motor fiber bundle as well as GMFM score between group I and group II was statistically insignificant. We conclude that addition of BTX to physiotherapy regimen does not influence the outcome at 6months with similar insult in children with term diplegic spastic CP. This information may influence management of diplegic CP especially in developing countries, where BTX is beyond the reach of these children.
Copyright © 2012 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23165172     DOI: 10.1016/j.braindev.2012.10.012

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  5 in total

Review 1.  Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy.

Authors:  Francesco C Blumetti; João Carlos Belloti; Marcel Js Tamaoki; José A Pinto
Journal:  Cochrane Database Syst Rev       Date:  2019-10-08

2.  GRIN: "GRoup versus INdividual physiotherapy following lower limb intra-muscular Botulinum Toxin-A injections for ambulant children with cerebral palsy: an assessor-masked randomised comparison trial": study protocol.

Authors:  Rachel E Thomas; Leanne M Johnston; Roslyn N Boyd; Leanne Sakzewski; Megan J Kentish
Journal:  BMC Pediatr       Date:  2014-02-07       Impact factor: 2.125

Review 3.  Multivariate Analysis and Machine Learning in Cerebral Palsy Research.

Authors:  Jing Zhang
Journal:  Front Neurol       Date:  2017-12-21       Impact factor: 4.003

4.  Assessment of the structural brain network reveals altered connectivity in children with unilateral cerebral palsy due to periventricular white matter lesions.

Authors:  Kerstin Pannek; Roslyn N Boyd; Simona Fiori; Andrea Guzzetta; Stephen E Rose
Journal:  Neuroimage Clin       Date:  2014-06-04       Impact factor: 4.881

5.  The Effect of Botulinum Toxin Injections on Gross Motor Function for Lower Limb Spasticity in Children with Cerebral Palsy.

Authors:  Ja Young Choi; Seung Ki Kim; Eun Sook Park
Journal:  Toxins (Basel)       Date:  2019-11-08       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.